Here is a Brand New Study About Vitamin C’s ability to be a Powerful Antiviral Agent
Vitamin C (Ascorbic Acid, AA) Antiviral Mechanisms (11) Direct antiviral mechanisms
Orthmolecular Medicine – Micheal J Gonzalez DSc, NMD, PhD, FANMA, FACN 2020
- Disruption of viral capsid by structurally interfering with the sugar moeity of its glycoprotein envelope.
- Damage of the viral capsid due to AA RedOx capacity when given in pharmacological doses.
- Inhibition of viral replication when provided in pharmacological doses by creating a hostile environment for this
activity to occur, in addition to inhibiting viral replication enzymes.
Indirect physiological mechanisms
- Increases cellular Immunity (White blood cells, neutrophils, macrophages, lymphocytes, Nk cells (Natural Killer Cells).
- Increases humoral immunity (B cells, antibodies).
- Increases antiviral proteins (Interferon).
- Increases energy by providing necessary electrons and electron movement for mitochondrial ATP generation.
- Limits the main source of fuel of pathogenic organisms, sugar, when provided in pharmacological doses.
- Potent, quick antioxidant action when provided in proper doses to prevent the dangerous and severe pathological cascade of the cytokine storm.
- Maintains structural integrity of cells by favoring collagen formation.
11. Modulates gene expression- Vitamin C administration decreases expression of susceptibility genes, including
mitochondrial antiviral signaling (MAVS) and interferon regulatory factor 3 (IRF3), and increased expression of NF-κB. These in conjunction induce type I interferons (IFNs) and elicit innate antiviral response.
Rev. 05/12/2020
References:
Gonzalez MJ, Miranda-Massari JR, Berdiel MJ, Duconge J, Rodríguez-López JL, Hunninghake R, Cobas-Rosario VJ. High dose intraveneous vitamin C and chikungunya fever: A case report. J Orthomolec Med, 2014;29(4):154- 156.
Gonzalez MJ, Berdiel MJ, Miranda-Massari JR, Duconge J, Rodríguez-López JL, Adrover-López PA. High dose intravenous vitamin C treatment for zika fever. J Orthomolec Med, 2016;31(1):19-22.
Gonzalez MJ, Berdiel MJ, Duconge J, Levy TE, Alfaro IM, Morales-Borges R, Marcial-Vega V, Olalde J. High Dose Intravenous Vitamin C and Influenza: A Case Report. J Orthomolec Med, 2018;33 (3):1-3.
Hunt C, Chakravorty NK, Annan G, Habibzadeh N, Schorah CJ. (1994) The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections. Int J Vitamin Nutr Res.64:212-219
Yejin Kim, Hyemin Kim, Seyeon Bae, Jiwon Choi, Sun Young Lim, Naeun Lee, Joo Myung Kong, Young-il Hwang, Jae Seung Kang, Wang Jae Lee. Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) Infection. Immune Netw. 2013 Apr; 13(2): 70–74.
Hemila H. Does vitamin C alleviate the symptoms of the common cold? A review of current evidence. Scand J Infect Dis 1994;26:1-6.
Hunt C, Chakravorty NK, Annan G, Habibzadeh H, Schorah CJ. The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections. Int J Vitam Nutr Res 1994;64:212-19.
Peters EM, Goetzsche JM, Grobbelaar B, Noakes TD. Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners. Am J Clin Nutr 1993;57:170-4.
Mandl, J.; Szarka, A.; Banhegyi, G. Vitamin C: Update on physiology and pharmacology. Br. J. Pharmacol. 2009, 157, 1097–1110.
Englard, S.; Seifter, S. The biochemical functions of ascorbic acid. Annu. Rev. Nutr. 1986, 6, 365– 406.
Bergsten, P.; Amitai, G.; Kehrl, J.; Dhariwal, K.R.; Klein, H.G.; Levine, M. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J. Biol. Chem. 1990, 265, 2584–2587.
Evans, R.M.; Currie, L.; Campbell, A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br. J. Nutr. 1982, 47, 473–482.
Tanaka, M.; Muto, N.; Gohda, E.; Yamamoto, I. Enhancement by ascorbic acid 2-glucoside or repeated additions of ascorbate of mitogen-induced IgM and IgG productions by human peripheral blood lymphocytes. Jpn. J. Pharmacol. 1994, 66, 451–456.
Chen, Y.; Luo, G.; Yuan, J.; Wang, Y.; Yang, X.; Wang, X.; Li, G.; Liu, Z.; Zhong, N. Vitamin C mitigatesoxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-inducedmacrophages. Mediators Inflamm. 2014, 2014, 426740.
Hajishengallis, G. Too old to fight? Aging and its toll on innate immunity. Mol. Oral Microbiol. 2010, 25, 25–37.
Cheng, L.; Cohen, M.; Bhagavan, H. Vitamin C and the elderly. In CRC Handbook of Nutrition in the Aged; Watson, R., Ed.; CRC Press Inc.: Boca Raton, FL, USA, 1985; pp. 157–185.
Simon, J.; Hudes, E.; Tice, J. Relation of serum ascorbic acid to mortality among US adults. J. Am. Coll. Nutr. 2001, 20, 255–263.
Fletcher, A.; Breeze, E.; Shetty, P. Antioxidant vitamins and mortality in older persons: Findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am. J. Clin. Nutr. 2003, 78, 999–1010.
Hunt, C.; Chakravorty, N.K.; Annan, G.; Habibzadeh, N.; Schorah, C.J. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int. J. Vitam. Nutr. Res. 1994, 64, 212–219.
Bharara, A.; Grossman, C.; Grinnan, D.; Syed, A.A.; Fisher, B.J.; DeWilde, C.; Natarajan, R.; Fowler, A.A. Intravenous vitamin C administered as adjunctive therapy for recurrent acute respiratory distress syndrome. Case Rep. Crit. Care 2016, 2016, 8560871.
Fowler, A.A.; Kim, C.; Lepler, L.; Malhotra, R.; Debesa, O.; Natarajan, R.; Fisher, B.J.; Syed, A.; DeWilde, C.; Priday, A.; et al. Intravenous vitamin C as adjunctive therapy for enterovirus/rhinovirus induced acute respiratory distress syndrome. World J. Crit. Care Med. 2017, 6, 85–90.
Vissers, M.C.; Wilkie, R.P. Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha. J. Leukoc. Biol.
2007, 81, 1236–1244.chwager J1, Bompard A1, Weber P1, Raederstorff D1. Ascorbic acid modulates cell migration in differentiated HL-60 cells and peripheral blood leukocytes. Mol Nutr Food Res. 2015 Aug;59(8):1513-23.
Shilotri, P.G. Phagocytosis and leukocyte enzymes in ascorbic acid deficient guinea pigs. J. Nutr. 1977, 107, 1513–1516
Anderson R. Effects of ascorbate on normal and abnormal leucocyte functions. Int J Vitam Nutr Res Suppl. 1982;23:23-34.
Sharma, P.; Raghavan, S.A.; Saini, R.; Dikshit, M. Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: Modulatory effect of nitric oxide. J. Leukoc. Biol. 2004, 75, 1070–1078
Vilchèze C, Kim J, Jacobs WR Jr. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First- Line Tuberculosis Drugs Isoniazid and Rifampin in Mice. Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02165-17..
Mitsuzumi H, Kusamiya M, Kurimoto T, Yamamoto I. Requirement of cytokines for augmentation of the antigen-specific antibody responses by ascorbate in cultured murine T-cell-depleted splenocytes. Jpn J Pharmacol. 1998 Oct;78(2):169-79.
Kim Y, Kim H, Bae S, Choi J, Lim SY, Lee N, Kong JM, Hwang YI, Kang JS, Lee WJ. Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) Infection. Immune Netw. 2013 Apr;13(2):70-4. doi: 10.4110/in.2013.13.2.70. Epub 2013 Apr 30.
Anderson, R.; Oosthuizen, R.; Maritz, R.; Theron, A.; Van Rensburg, A.J. The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers. Am. J. Clin. Nutr. 1980, 33, 71–76.
Bozonet, S.M.; Carr, A.C.; Pullar, J.M.; Vissers, M.C.M. Enhanced human neutrophil vitamin C status, chemotaxis and oxidant generation following dietary supplementation with vitamin C-rich SunGold kiwifruit. Nutrients 2015, 7, 2574–2588.
Vorilhon P, Arpajou B, Vaillant Roussel H, Merlin É, Pereira B, Cabaillot A. Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children. Eur J Clin Pharmacol. 2019 Mar;75(3):303-311. doi: 10.1007/s00228-018-2601-7.
Kim GN, Yoo WS, Park MH, Chung JK, Han YS, Chung IY, Seo SW, Yoo JM, Kim SJ. Clinical Features of Herpes Simplex Keratitis in a Korean Tertiary Referral Center: Efficacy of Oral Antiviral and Ascorbic Acid on Recurrence.Korean J Ophthalmol. 2018 Oct;32(5):353-360.
Gao YL, Lu B, Zhai JH1, Liu YC, Qi HX, Yao Y, Chai YF, Shou ST. The Parenteral Vitamin C Improves Sepsis and Sepsis-Induced Multiple Organ Dysfunction Syndrome via Preventing Cellular Immunosuppression. Mediators Inflamm. 2017;2017:4024672.
Kim SR, Ha YM, Kim YM, Park EJ, Kim JW, Park SW, Kim HJ, Chung HT, Chang KC. Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/HO-1 signals. Biochem Pharmacol. 2015 Jun 15;95(4):279- 89.
Furuya A, Uozaki M, Yamasaki H, Arakawa T, Arita M, Koyama AH. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Int J Mol Med. 2008 Oct;22(4):541-5.
Mikirova N, Hunninghake R.Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit. 2014 May 3;20:725-32.
Schencking M1, Vollbracht C, Weiss G, Lebert J, Biller A, Goyvaerts B, Kraft K. Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study. Med Sci Monit. 2012 Apr;18(4):CR215-24.
Chen S, Zhao W, Zhang B, Jia Y, Wu S, Zhong B, Yu X, Wang X, Hao Y, ang H, Zhao Y, Mizuno K, Bu H, Tseng Y5Clinical Effect of Intravenous Vitamin C on Viral Myocarditis in Children: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2019;23;2019:3082437.
Marcial-Vega V, Gonzalez-Terron I, Levy TE. Intravenous Ascorbic Acid And Hydrogen Peroxide In The Management Of Patients With Chikungunya. Bol Asoc Med. 2017;107(1):20-24.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034.
Marik PE, Vitamin C. for the treatment of sepsis: the scientific rationale. Pharmacol Therapeut 2018;189:63–70.
Marik PE, Hydrocortisone. Ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid. Nutrients 2018;10:1762.
Wonderful vitamin C
YES 😀🙏🏻❤️